Dr. Bruce D. Given

• 
  www.primezone.com/newsroom/news.html?d=115029 - [Cached Version]
  Published on: 3/7/2007    Last Visited: 3/12/2007  

  "Approval in Australia marks another proud achievement for Encysive's global THELIN development program," commented Bruce D. Given, M.D., President and Chief Executive Officer of Encysive Pharmaceuticals.

• 
  www.sembiosys.ca/About/Bio.aspx?name=BGiven - [Cached Version]
  Published on: 9/16/2008    Last Visited: 9/16/2008  

  Bruce D. Given, M.D.SemBioSys - Biography
  ...
  Bruce D. Given, M.D.
  
  Acting Chief Medical Officer
  
  Dr. Bruce Given serves as a Healthcare Products Consultant as the Principal of Bruce Given Consulting and is Acting Chief Medical Officer of SemBioSys Genetics Inc.Until June of 2007, Dr. Given served as President and Chief Executive Officer and as a member of the Board of Directors of Encysive Pharmaceuticals, which he joined in 2002.Prior to joining Encysive Pharmaceuticals, he was with Johnson & Johnson for nine years, serving in several capacities including as President, International, Ortho-Clinical Diagnostics and as Group Vice President, Head of U.S. Marketing & Sales, Research & Development for Janssen Pharmaceutica.He has held various executive and senior management positions at Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation.Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago.
  
  Dr. Given obtained his B.Sc degree from Colorado State University, graduating Phi Beta Kappa.He received his M.D. degree with honors from the University of Chicago, Pritzker School of Medicine and completed his medical training at the University of Chicago and at Brigham and Women's Hospital in Boston, where he was a Clinical Fellow at Harvard Medical School.He is board certified in internal medicine and endocrinology and metabolism and has authored 33 scientific publications.
  
  Dr. Given serves on the Boards of Directors for ICON Plc and BioHouston, where he is Secretary of the Executive Committee of the Board, is a member of the Technology Review Committee of MD Anderson Medical Center and is past Chairman of the Rider University Scientific Advisory Board.

• 
  ir.encysive.com/ireye/ir_site.zhtml?ticker=ency&script= - [Cached Version]
  Published on: 10/15/2008    Last Visited: 5/16/2008  

  Bruce D. Given, M.D., President and Chief Executive Officer of Texas Biotechnology stated, "We have worked diligently to refine our strategic plan and identify the products and programs that have the greatest probability for commercial success.We believe this restructuring, in addition to the rigorous cost controlling measures we implemented in 2002, will allow us to retain the Company's proven core competencies in drug discovery and development, and provide ample support for the products and programs most likely to accelerate Texas Biotechnology's transition into a profitable pharmaceutical company."
  
  Dr. Given added, "Near-term, our primary emphasis will be focused on the Phase III development and commercialization of sitaxsentan, which we believe is key to building sustainable shareholder value."

• 
  www.tbc.com/about_team.html - [Cached Version]
  Published on: 3/1/2007    Last Visited: 3/1/2007  

  Bruce D. Given, M.D.
  ...
  Bruce D. Given, M.D.President and Chief Executive OfficerBruce D. Given, M.D. has served as our President and Chief Executive Officer and as a member of the board of directors since March 2002.Dr. Given joined us after eight years with Johnson & Johnson, most recently serving as President, International of Ortho-Clinical Diagnostics from May 2000 to March 2002.He was also General Manager of Transfusion Medicine Worldwide of Ortho-Clinical Diagnostics from November 1999 to May 2000.Dr. Given served as Group Vice President, head of Worldwide Clinical and Regulatory Affairs of Biosense Webster from July 1998 to November 1999.He was also Group Vice President, head of U.S. Marketing & Sales, Research & Development for Janssen Pharmaceutica from April 1995 to July 1998.Prior to Johnson & Johnson, he held various executive and senior management positions with Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation.Dr. Given currently serves on the MD Anderson Technology Review Committee.He received a B.S. from Colorado State University, an M.D. with honors from the University of Chicago and was a Clinical Fellow at Harvard Medical School.

• 
  ir.encysive.com/ireye/ir_site.zhtml?ticker=ency&script= - [Cached Version]
  Published on: 5/29/2002    Last Visited: 5/16/2008  

  HOUSTON, May 29, 2002 /PRNewswire-FirstCall via COMTEX/ -- Texas Biotechnology Corporation (Nasdaq: TXBI) announced today that Bruce Given, M.D., Texas Biotechnology President and CEO will speak at the First Annual Needham & Company Biotechnology Conference on Tuesday, June 4, 2002 at 3:30 p.m. ET.

• 
  ir.encysive.com/ireye/ir_site.zhtml?ticker=ency&script= - [Cached Version]
  Published on: 5/1/2002    Last Visited: 5/16/2008  

  Bruce D. Given, M.D., President and CEO of Texas Biotechnology stated, "As the new president and CEO of Texas Biotechnology, I am pleased that the first quarter results for Texas Biotechnology are in line with our expectations.
  ...
  On March 25, 2002 Bruce D. Given, M. D., joined Texas Biotechnology as President, Chief Executive Officer and a member of the Board of Directors.Dr. Given succeeds David B. McWilliams who retired from the Company after serving as its President and Chief Executive Officer since 1992.
  ...
  Dr. Given has an extensive background in marketing, sales, R&D and clinical development and has held several leadership positions at Johnson & Johnson.Most recently, Dr. Given was President, International of Ortho-Clinical Diagnostics.

• 
  biz.yahoo.com/ap/070619/encysive_a_second_look.html?.v= - [Cached Version]
  Published on: 6/19/2007    Last Visited: 6/19/2007  

  President and Chief Executive Bruce Given said the agency is examining the results in a way that is different from the manner agreed upon by the FDA and Encysive.

• 
  houston.bizjournals.com/houston/stories/2007/05/07/dail - [Cached Version]
  Published on: 5/7/2007    Last Visited: 5/8/2007  

  Encysive Pharmaceuticals, Dr. Bruce Given,
  ...
  "In the quarter, we made significant progress advancing our regulatory and product commercialization plans," said Dr. Bruce Given, president and chief executive officer.

• 
  ir.encysive.com/ireye/ir_site.zhtml?ticker=ency&script= - [Cached Version]
  Published on: 6/19/2002    Last Visited: 5/16/2008  

  Bruce D. Given, M.D., President and CEO, Texas Biotechnology, stated, "The successful optimization of several small molecule VLA-4 antagonists is encouraging and attests to the strength of our research efforts in two areas: the identification of key vascular targets and the development of novel small molecule drugs."

• 
  wwwtest.forbes.com/feeds/ap/2007/07/16/ap3916389.html - [Cached Version]
  Published on: 7/16/2007    Last Visited: 7/16/2007  

  Biotechnology company Encysive Pharmaceuticals Inc. said Monday board member, and former president and chief executive, Dr. Bruce D. Given resigned his position as a director.
  
  Given resigned Thursday, according to a Securities and Exchange Commission filing.

Page:  1 2 3 4 5